Allergy News and Info
| Mold in my home: What do I do? – Molds are simple, microscopic organisms, present virtually everywhere, indoors and outdoors. read more
Specialized testing for pediatric respiratory disease. See -how we use the latest tools to treat allergies and asthma. read more Mold Evaluations – Is mold a problem in your home? Mold intrusion problems & complaints. read more Eliminating CFC-Albuterol – read more Latex Allergy Testing – Latex skin reagent diagnostic testing. Our reagents were prepared to approximate the strengths of the latex extracts of a multi-center national latex skin test trial… read more Latex Gloves- These are the new latex gloves approved by the FDA. read more Alpha-1 Antitrypsin Deficiency – Free screening test. This is an under recognized disorder that can involve the lungs, liver and less commonly skin. read more Most Patients With Moderate to Severe Asthma Have Suboptimal Control – Most patients with moderate to severe asthma in the United States live with poorly controlled disease, according to investigators who presented the results of the Real-world Evaluation of Asthma Control and Treatment (REACT). read more FDA Proposes to Strengthen Label Warning for Xolair – Today the Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab, marketed as Xolair. The boxed warning emphasizes that Xolair, used to treat patients with asthma related to allergies, may cause anaphylaxis. read more FDA Approves New Food Allergy Labeling Law – Effective January 1, 2006, manufacturers are required to list the presence of certain ingredients (such as milk, peanuts, egg, tree nuts, shellfish, fish, wheat and soy) in food products. They will also be required to list any of the aforementioned ingredients when used as flavorings, additives, or colorings in food products. The purpose of this law is to protect allergic patients from unseen and/or unintentional exposures. read more FDA Approves Updated Labeling with Boxed Warning and Medication Guide for Two Eczema Drugs, Elidel and Protopic – The FDA released updated product labels for the calcineurin inhibitors, pimecrolimus and tacrolimus. Pimecrolimus is marketed in the United States by Novartis as Elidel cream. Tacrolimus is marketed in the United States by Astellas Pharma as Protopic ointment. read more Latest Air Info: |